Antonella Chadha Santuccione, Ph.D. is a medical doctor with profound expertise in clinical pathology, neuroscience, and psychiatric disorders.
Currently, she works as a Global Medical Manager for Alzheimer’s disease at Roche Diagnostic. She is the Chief Executive Officer, Strategic Lead Officer, and cofounder at Women’s Brain Project. As a medical doctor, Antonella has decades of experience in preclinical research, patient treatment, clinical development, and setting up the international regulatory framework for Alzheimer’s disease. Always focused on solving the puzzles related to Alzheimer’s and other psychiatric diseases, she has worked with Swissmedic, the Bill and Melinda Gates Foundation, several European universities, the EU commission for Health and Food Safety, the World Health Organization, and several Alzheimer’s’ disease organizations. In 2018, Antonella was nominated in the TOP 100 Women in Business in Switzerland, and in 2019 she was nominated as one of the most prominent people in the city of Basel. Antonella is keenly interested in removing bias so that precision medicine and novel technologies can be delivered to patients in a more precise and timely manner. She is advocating and acting for the creation of an Institute for sex and gender precision medicine in Switzerland.